Stock Research: Raffles Medical Group

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Raffles Medical Group

SGX:BSL SG1CH4000003
42
  • Value
    15
  • Growth
    57
  • Safety
    Safety
    30
  • Combined
    8
  • Sentiment
    100
  • 360° View
    360° View
    42
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Raffles Medical Group Ltd is a Singapore-based integrated private healthcare provider. It operates in Healthcare Services, Hospital Services, and Investment Holdings. The company has facilities in Singapore, China, Japan, Vietnam, and Cambodia. In the last fiscal year, the company had a market cap of $1,481 million, profits of $478 million, revenue of $551 million, and 2,989 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 42 (better than 42% compared with alternatives), overall professional sentiment and financial characteristics for the stock Raffles Medical Group are below the industry average. The 360° View is based on consolidating four consolidated indicators, with half of the metrics below and half above average for Raffles Medical Group. The consolidated Growth Rank has a good rank of 57, which means that the company experiences above-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is higher than for 57% of competitors in the same industry. The consolidated Sentiment Rank also has a good rank of 100, which means that professional investors are more optimistic about the stock than for 100% of alternative investment opportunities. But the consolidated Value Rank has a less desirable rank of 30, which means that the share price of Raffles Medical Group is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 70% of alternative stocks in the same industry. Finally, the consolidated Safety Rank has a riskier rank of 15, which means that the company has a financing structure that is riskier than those of 85% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
30 49 41 43
Growth
57 1 1 87
Safety
Safety
15 20 32 28
Sentiment
100 47 86 94
360° View
360° View
42 10 15 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
87 30 37 51
Opinions Change
50 50 50 50
Pro Holdings
n/a 27 79 90
Market Pulse
95 94 93 100
Sentiment
100 47 86 94
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
30 49 41 43
Growth
57 1 1 87
Safety Safety
15 20 32 28
Combined
8 4 4 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
26 34 34 25
Price vs. Earnings (P/E)
36 43 37 41
Price vs. Book (P/B)
40 54 37 49
Dividend Yield
61 85 78 54
Value
30 49 41 43
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
26 11 8 52
Profit Growth
47 12 10 44
Capital Growth
64 27 37 69
Stock Returns
79 9 11 93
Growth
57 1 1 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
45 45 66 50
Refinancing
20 26 24 22
Liquidity
34 33 42 29
Safety Safety
15 20 32 28

Similar Stocks

Discover high‑ranked alternatives to Raffles Medical Group and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

UOL Group

SGX:U14
Country: Singapore
Industry: Real Estate: Diversified Operations
Size: Medium
Full Stock Analysis

Sumitomo Forestry

TSE:1911
Country: Japan
Industry: Homebuilding
Size: X-Large
Full Stock Analysis

Genting Singapore

SGX:G13
Country: Singapore
Industry: Casinos & Gaming
Size: Medium
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.